Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19121652.
- Also identified by DOI 10.1016/j.ajog.2008.08.048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent studies have demonstrated efficacy of bevacizumab for recurrent ovarian cancer, but few data on its use and gastrointestinal potential complications when administered as adjuvant chemotherapy after cytoreductive surgery are available. In this study, we report the first case of a rectovaginal fistula in this indication.
Medical subject headings
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Ovarian Neoplasms
- Rectovaginal Fistula